Review immune response of targeting CD39 in cancer

The ATP-adenosine pathway has emerged as a promising target for cancer therapy, but challenges remain in achieving effective tumor control. Early research focused on blocking the adenosine generating enzyme CD73 and the adenosine receptors A2AR or A2BR in cancer. However, recent studies have shown t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yao, Li, Zhongliang, Zhao, Xiaoguang, Xiao, Jing, Bi, Jiacheng, Li, Xian-Yang, Chen, Guokai, Lu, Ligong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249319/
https://www.ncbi.nlm.nih.gov/pubmed/37287049
http://dx.doi.org/10.1186/s40364-023-00500-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249319/
https://www.ncbi.nlm.nih.gov/pubmed/37287049
http://dx.doi.org/10.1186/s40364-023-00500-w

Ejemplares similares